Provided by Tiger Fintech (Singapore) Pte. Ltd.

Moderna, Inc.

26.71
+0.30001.14%
Post-market: 26.710.00000.00%17:14 EST
Volume:9.47M
Turnover:251.23M
Market Cap:10.44B
PE:-3.32
High:27.10
Open:26.07
Low:25.97
Close:26.41
52wk High:48.92
52wk Low:23.04
Shares:390.68M
Float Shares:363.29M
Volume Ratio:0.80
T/O Rate:2.61%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.0516
EPS(LYR):-9.2734
ROE:-29.32%
ROA:-15.49%
PB:1.12
PE(LYR):-2.88

Loading ...

Post-Bell | U.S. Stocks End Lower; TSMC Jumps 4%; Tesla Falls 2%; Nvidia and Amazon Drop 3%; Oracle Sinks 4%

Tiger Newspress
·
Sep 24

Moderna Inc. Stock Sheds 2.9%, Underperforms Peers

Dow Jones
·
Sep 24

Brookline Capital Markets Reaffirms Their Buy Rating on Moderna (MRNA)

TIPRANKS
·
Sep 24

William Blair Sticks to Its Hold Rating for Moderna (MRNA)

TIPRANKS
·
Sep 24

Moderna Says Second Covid-19 Vaccine Generates Strong Immune Response

Dow Jones
·
Sep 23

BRIEF-Moderna Announces Positive Prelim Immunogenicity Data For 2025-2026 Formula Of mNEXSPIKE

Reuters
·
Sep 23

Moderna: Safety Profile of Vaccine Consistent With Previous Studies

THOMSON REUTERS
·
Sep 23

Moderna: Positive Prelim Immunogenicity Data for 2025-2026 Formula of Mnexspike, Which Targets Lp.8.1 Variant of Sars-Cov-2

THOMSON REUTERS
·
Sep 23

Moderna: Prelim Analysis Showed 2025-2026 Formula of Mnexspike Generated >16-Fold Increase in Lp.8.1-Neutralizing Antibodies Across Age Groups

THOMSON REUTERS
·
Sep 23

Moderna Inc. Stock Advances 5.2%, Outperforms Peers

Dow Jones
·
Sep 23

Stock Track | Moderna Soars 7.13% as Investors Focus on Pipeline Potential and Canadian Manufacturing Milestone

Stock Track
·
Sep 23

BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT

Reuters
·
Sep 23

Could Moderna’s (MRNA) Index Exit Shift Focus From COVID-19 Hurdles to Pipeline Priorities?

Simply Wall St.
·
Sep 22

Moderna: Announces First Made-in-Canada Mrna Vaccines Delivered to Canadian Provinces and Territories

THOMSON REUTERS
·
Sep 20

Moderna Inc. Stock Rises 4.0%, Outperforms Peers

Dow Jones
·
Sep 17

Moderna, Inc. Surges 4.8% in Late Trading

Deep News
·
Sep 17

Stock Track | Moderna Soars 5.03% as New COVID-19 Vaccine Shows Strong Immune Response Against Dominant Variant

Stock Track
·
Sep 17

Stock Track | Moderna Soars 5.03% as 2025-2026 COVID-19 Vaccine Shows Strong Immune Response

Stock Track
·
Sep 17

Moderna Says New Covid-19 Vaccine Generates Strong Response Against Variant

Dow Jones
·
Sep 16

NANO MRNA Advances RUNX1 mRNA Clinical Trial for Osteoarthritis

TIPRANKS
·
Sep 16